Pentadecanoic and Heptadecanoic Acids: Multifaceted Odd-Chain Fatty Acids.
暂无分享,去创建一个
[1] J. Rieusset,et al. Contribution of mitochondria and endoplasmic reticulum dysfunction in insulin resistance: Distinct or interrelated roles? , 2015, Diabetes & metabolism.
[2] J. Vockley,et al. Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment--A retrospective chart review. , 2015, Molecular genetics and metabolism.
[3] M. Blaut,et al. Effects of dietary inulin on bacterial growth, short-chain fatty acid production and hepatic lipid metabolism in gnotobiotic mice. , 2015, The Journal of nutritional biochemistry.
[4] J. Klein,et al. Reduced severity of ischemic stroke and improvement of mitochondrial function after dietary treatment with the anaplerotic substance triheptanoin , 2015, Neuroscience.
[5] R. Frye,et al. Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome , 2015, Microbial ecology in health and disease.
[6] W. Ratnayake,et al. Concerns about the use of 15:0, 17:0, and trans-16:1n-7 as biomarkers of dairy fat intake in recent observational studies that suggest beneficial effects of dairy food on incidence of diabetes and stroke. , 2015, The American journal of clinical nutrition.
[7] T. Baars,et al. Fatty acid profiles and antioxidants of organic and conventional milk from low- and high-input systems during outdoor period. , 2015, Journal of the science of food and agriculture.
[8] A. Koulman,et al. A Review of Odd-Chain Fatty Acid Metabolism and the Role of Pentadecanoic Acid (C15:0) and Heptadecanoic Acid (C17:0) in Health and Disease , 2015, Molecules.
[9] R. Crescenzo,et al. Mitochondrial efficiency and insulin resistance , 2015, Front. Physiol..
[10] N. Turner,et al. Mitochondrial dysfunction and insulin resistance: an update , 2014, Endocrine connections.
[11] M. Rewers,et al. Serum pentadecanoic acid (15:0), a short-term marker of dairy food intake, is inversely associated with incident type 2 diabetes and its underlying disorders. , 2014, The American journal of clinical nutrition.
[12] D. Mozaffarian,et al. Circulating biomarkers of dairy fat and risk of incident stroke in U.S. men and women in 2 large prospective cohorts. , 2014, The American journal of clinical nutrition.
[13] R. Golley,et al. Evaluation of the Relative Concentration of Serum Fatty Acids C14:0, C15:0 and C17:0 as Markers of Children's Dairy Fat Intake , 2014, Annals of Nutrition and Metabolism.
[14] A. Kihara,et al. Identification of the phytosphingosine metabolic pathway leading to odd-numbered fatty acids , 2014, Nature Communications.
[15] Min Jung Park,et al. Anaplerotic Triheptanoin Diet Enhances Mitochondrial Substrate Use to Remodel the Metabolome and Improve Lifespan, Motor Function, and Sociability in MeCP2-Null Mice , 2014, PloS one.
[16] Albert Koulman,et al. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study , 2014, The lancet. Diabetes & endocrinology.
[17] R. Calvani,et al. The interplay between autophagy and mitochondrial dysfunction in oxidative stress-induced cardiac aging and pathology. , 2014, Journal of molecular and cellular cardiology.
[18] H. Eyles,et al. Plasma and erythrocyte fatty acids reflect intakes of saturated and n-6 PUFA within a similar time frame. , 2014, The Journal of nutrition.
[19] A. Csiszar,et al. Mitochondria in Cardiovascular Physiology and Disease Role of mitochondrial dysfunction and altered autophagy in cardiovascular aging and disease : from mechanisms to therapeutics , 2013 .
[20] D. Mozaffarian,et al. Biomarkers of Dairy Fatty Acids and Risk of Cardiovascular Disease in the Multi‐Ethnic Study of Atherosclerosis , 2013, Journal of the American Heart Association.
[21] D. Mozaffarian,et al. trans-Palmitoleic acid, other dairy fat biomarkers, and incident diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2013, The American journal of clinical nutrition.
[22] J. Kanda,et al. Comparison of catabolism rate of fatty acids to carbon dioxide in mice , 2012 .
[23] E. Riboli,et al. Plasma Phospholipid Fatty Acid Concentration and Incident Coronary Heart Disease in Men and Women: The EPIC-Norfolk Prospective Study , 2012, PLoS medicine.
[24] M. Wajner,et al. Disruption of mitochondrial homeostasis in organic acidurias: insights from human and animal studies , 2011, Journal of bioenergetics and biomembranes.
[25] M. Schulze,et al. Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. , 2011, The American journal of clinical nutrition.
[26] M. Peppelenbosch,et al. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. , 2010, Biochimica et biophysica acta.
[27] S. Sharp,et al. Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes: a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort. , 2010, The American journal of clinical nutrition.
[28] G. Hallmans,et al. Biomarkers of milk fat and the risk of myocardial infarction in men and women: a prospective, matched case-control study. , 2010, The American journal of clinical nutrition.
[29] H. Hama. Fatty acid 2-Hydroxylation in mammalian sphingolipid biology. , 2010, Biochimica et biophysica acta.
[30] L. Hellgren. Phytanic acid—an overlooked bioactive fatty acid in dairy fat? , 2010, Annals of the New York Academy of Sciences.
[31] J. Griffin,et al. Metabolic phenotyping of a model of adipocyte differentiation. , 2009, Physiological genomics.
[32] A. Folsom,et al. Plasma fatty acid composition and incident heart failure in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. , 2008, American heart journal.
[33] L. Weinehall,et al. Fatty acid profile of the erythrocyte membrane preceding development of Type 2 diabetes mellitus. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[34] A. Roddam,et al. Phytanic acid: measurement of plasma concentrations by gas–liquid chromatography–mass spectrometry analysis and associations with diet and other plasma fatty acids , 2008, British Journal of Nutrition.
[35] I. Elmadfa,et al. Very Low n–3 Long-Chain Polyunsaturated Fatty Acid Status in Austrian Vegetarians and Vegans , 2008, Annals of Nutrition and Metabolism.
[36] N. Gotoh,et al. Metabolism of odd-numbered fatty acids and even-numbered fatty acids in mouse. , 2008, Journal of oleo science.
[37] F. Hu,et al. Plasma and erythrocyte biomarkers of dairy fat intake and risk of ischemic heart disease. , 2007, The American journal of clinical nutrition.
[38] D. English,et al. Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. , 2007, The American journal of clinical nutrition.
[39] A. Beynen,et al. Effect of dietary fat type on meat quality and fatty acid composition of various tissues in growing-finishing swine. , 2007, Meat science.
[40] N. Radin,et al. Metabolism of brain glycolipid fatty acids , 2007, Lipids.
[41] R. Rodenburg,et al. Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins. , 2006, The Biochemical journal.
[42] R. Dahiya,et al. Distribution of glycosphingolipids and ceramide of rat small intestinal mucosa , 1986, Lipids.
[43] L. Weinehall,et al. Estimated intake of milk fat is negatively associated with cardiovascular risk factors and does not increase the risk of a first acute myocardial infarction. A prospective case–control study , 2004, British Journal of Nutrition.
[44] C. Roe,et al. Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. , 2002, The Journal of clinical investigation.
[45] T. Suormala,et al. Odd-numbered long-chain fatty acids in propionic acidaemia , 2000, European Journal of Pediatrics.
[46] J. I. Pedersen,et al. Peroxisomal oxidation of the steroid side chain in bile acid formation. , 1993, Biochimie.
[47] J. I. Pedersen,et al. Metabolic aspects of peroxisomal β-oxidation , 1991 .
[48] J. I. Pedersen,et al. Metabolic aspects of peroxisomal beta-oxidation. , 1991, Biochimica et biophysica acta.
[49] G. Donnell,et al. Propionate metabolism by cultured skin fibroblasts from normal individuals and patients with methylmalonicaciduria and propionicacidemia. , 1981, Biochemical medicine.
[50] D. Steinberg,et al. Identification of propionate as a degradation product of phytanic acid oxidation in rat and human tissues. , 1973, The Journal of biological chemistry.
[51] H. Moser,et al. Branched-chain and odd-numbered fatty acids and aldehydes in the nervous system of a patient with deranged vitamin B 12 metabolism. , 1973, Journal of lipid research.
[52] S. Ställberg-Stenhagen,et al. Changes in the fatty acid composition of cerebrosides and sulfatides of human nervous tissue with age. , 1968, Journal of lipid research.
[53] J. Dodge,et al. Composition of phospholipids and of phospholipid fatty acids of human plasma. , 1967, Journal of lipid research.
[54] N. Radin,et al. Biosynthesis of the cerebroside odd-numbered fatty acids , 1962 .
[55] N. Radin,et al. Composition of cerebroside acids as a function of age , 1959 .